Archive: 2026/01 - Page 3

How to Monitor Your Symptoms After a Safety Communication: A Step-by-Step Guide 8 January 2026

How to Monitor Your Symptoms After a Safety Communication: A Step-by-Step Guide

Learn how to track symptoms after a drug or device safety alert. Step-by-step guide on what to watch for, when to report, and how to use tools safely to protect your health.

Compounding Pharmacies: Alternatives When Drugs Are Unavailable 6 January 2026

Compounding Pharmacies: Alternatives When Drugs Are Unavailable

When drugs are unavailable due to shortages or allergies, compounding pharmacies create custom medications tailored to individual needs-offering solutions like allergen-free formulas, flavored liquids, and precise dosages that big manufacturers can't provide.

Tentative Approval for Generics: Common Reasons for Delays 5 January 2026

Tentative Approval for Generics: Common Reasons for Delays

Tentative approval from the FDA means a generic drug is scientifically ready-but legal, manufacturing, or market barriers often delay its launch for years. Here’s why affordable alternatives still take so long to reach patients.

Manufacturing Challenges for Biosimilars: Complex Production Explained 3 January 2026

Manufacturing Challenges for Biosimilars: Complex Production Explained

Biosimilars are complex biologic drugs that can't be copied like generic pills. Their production requires precise control over living cells, glycosylation, and scaling - making them far harder and costlier to manufacture than traditional generics.